FdaApplication
ANDA 218069
Identifiers
- fda_app_no: ANDA218069
Properties
| Property | Value |
|---|---|
| applicant_name | NOVAST LABS LTD |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN | 50MG | TABLET, EXTENDED RELEASE |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN | 500MG | TABLET, EXTENDED RELEASE |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN | EQ 100MG BASE TABLET | TABLET, EXTENDED RELEASE |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE, SITAGLIPTIN | 1000MG | TABLET, EXTENDED RELEASE |
4 products